Prednisone + Jakavi(ruxolitinib)
CINC424DKR01T
Phase 2 small_molecule active
Quick answer
Prednisone + Jakavi(ruxolitinib) for GVHD - Graft-Versus-Host Disease is a Phase 2 program (small_molecule) at Yung NA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Yung NA
- Indication
- GVHD - Graft-Versus-Host Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active